Transgenomic Inc Stock OTC Bulletin Board
Equities
TBIO
US89365K2069
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- USD | - |
05-14 | Precipio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-19 | Precipio, Inc. announced that it expects to receive $0.5 million in funding | CI |
Sales 2022 | 9.41M 12.82M | Sales 2023 | 15.2M 20.71M | Capitalization | 9.23M 12.58M |
---|---|---|---|---|---|
Net income 2022 | -12M -16.35M | Net income 2023 | -5M -6.81M | EV / Sales 2022 | 1.12 x |
Net cash position 2022 | 2.05M 2.8M | Net cash position 2023 | 386K 526K | EV / Sales 2023 | 0.58 x |
P/E ratio 2022 |
-1.03
x | P/E ratio 2023 |
-1.44
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 93.88% |
Latest transcript on Transgenomic Inc
Managers | Title | Age | Since |
---|---|---|---|
Ilan Danieli
CEO | Chief Executive Officer | 52 | 17-06-27 |
Matthew Gage
DFI | Director of Finance/CFO | 57 | 17-06-30 |
Ayman Mohamed
CTO | Chief Tech/Sci/R&D Officer | 39 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Ronald Andrews
BRD | Director/Board Member | 64 | 21-02-28 |
Kathy LaPorte
BRD | Director/Board Member | 62 | 18-08-08 |
Richard Sandberg
CHM | Chairman | 80 | 19-12-02 |
1st Jan change | Capi. | |
---|---|---|
-27.52% | 16.33B | |
-40.04% | 2.96B | |
+15.16% | 1.82B | |
-6.86% | 1.55B | |
+38.67% | 1.41B | |
-15.36% | 976M | |
-26.08% | 846M | |
+3.53% | 811M | |
-24.63% | 631M |
- Stock Market
- Equities
- PRPO Stock
- TBIO Stock